Details
Stereochemistry | ACHIRAL |
Molecular Formula | C15H14N2O4S |
Molecular Weight | 318.348 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
ONC(=O)\C=C\C1=CC(=CC=C1)S(=O)(=O)NC2=CC=CC=C2
InChI
InChIKey=NCNRHFGMJRPRSK-MDZDMXLPSA-N
InChI=1S/C15H14N2O4S/c18-15(16-19)10-9-12-5-4-8-14(11-12)22(20,21)17-13-6-2-1-3-7-13/h1-11,17,19H,(H,16,18)/b10-9+
Molecular Formula | C15H14N2O4S |
Molecular Weight | 318.348 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 1 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:35:41 UTC 2023
by
admin
on
Fri Dec 15 15:35:41 UTC 2023
|
Record UNII |
F4H96P17NZ
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000175588
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
||
|
WHO-ATC |
L01XX49
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
||
|
FDA ORPHAN DRUG |
289309
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
||
|
NCI_THESAURUS |
C1946
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/13/1151
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
CHEMBL408513
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
C48812
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
DTXSID60194378
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
m2295
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | Merck Index | ||
|
7496
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
726630
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
SS-19
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
1543543
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | RxNorm | ||
|
61076
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
8823
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
F4H96P17NZ
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
4876
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
F4H96P17NZ
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
100000144569
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
866323-14-0
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
6918638
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
BELINOSTAT
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
414864-00-9
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
NON-SPECIFIC STEREOCHEMISTRY | |||
|
SUB121262
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY | |||
|
DB05015
Created by
admin on Fri Dec 15 15:35:41 UTC 2023 , Edited by admin on Fri Dec 15 15:35:41 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->LIGAND | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
METABOLIC ENZYME -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE INACTIVE -> PARENT |
MEDIATOR: UGT1A1
MAJOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
The enzymes responsible for the formation of 3-(anilinosulfonyl)-benzenecarboxylic acid, (3-ASBA) are not known.
|
||
|
METABOLITE -> PARENT |
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
Belinostat also undergoes hepatic metabolism by CYP2A6, CYP2C9, and CYP3A4 enzymes to form belinostat amide and belinostat acid.
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
Belinostat also undergoes hepatic metabolism by CYP2A6, CYP2C9, and CYP3A4 enzymes to form belinostat amide and belinostat acid.
MAJOR
PLASMA; URINE
|
||
|
METABOLITE -> PARENT |
MAJOR
PLASMA; URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
|
|||